165 related articles for article (PubMed ID: 27444613)
1. Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Langner E; Lemieszek MK; Kwiecień JM; Rajtar G; Rzeski W; Turski WA
Neurochem Res; 2017 Mar; 42(3):838-845. PubMed ID: 27444613
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93).
Wejksza K; Rzeski W; Okuno E; Kandefer-Szerszen M; Albrecht J; Turski WA
Neurochem Res; 2005 Aug; 30(8):963-8. PubMed ID: 16258845
[TBL] [Abstract][Full Text] [Related]
3. Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord.
Dabrowski W; Kwiecien JM; Rola R; Klapec M; Stanisz GJ; Kotlinska-Hasiec E; Oakden W; Janik R; Coote M; Frey BN; Turski WA
PLoS One; 2015; 10(11):e0142598. PubMed ID: 26562835
[TBL] [Abstract][Full Text] [Related]
4. Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.
Di Serio C; Cozzi A; Angeli I; Doria L; Micucci I; Pellerito S; Mirone P; Masotti G; Moroni F; Tarantini F
Cell Mol Neurobiol; 2005 Sep; 25(6):981-93. PubMed ID: 16392031
[TBL] [Abstract][Full Text] [Related]
5. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
6. Kynurenic acid inhibits glutamatergic transmission to CA1 pyramidal neurons via α7 nAChR-dependent and -independent mechanisms.
Banerjee J; Alkondon M; Albuquerque EX
Biochem Pharmacol; 2012 Oct; 84(8):1078-87. PubMed ID: 22889930
[TBL] [Abstract][Full Text] [Related]
7. Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding.
Chess AC; Bucci DJ
Behav Brain Res; 2006 Jun; 170(2):326-32. PubMed ID: 16621049
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
9. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
10. Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists.
Zarnowski T; Bialek M; Rejdak R; Zrenner E; Junemann A; Zagorski Z; Kocki T; Turski WA
J Neural Transm (Vienna); 2006 Oct; 113(10):1367-72. PubMed ID: 16465462
[TBL] [Abstract][Full Text] [Related]
11. Kynurenic acid attenuates NMDA-induced pial arteriolar dilation in newborn pigs.
Bari F; Nagy K; Guidetti P; Schwarcz R; Busija DW; Domoki F
Brain Res; 2006 Jan; 1069(1):39-46. PubMed ID: 16388784
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases.
Senggunprai L; Yoshinari K; Yamazoe Y
Biochem J; 2009 Aug; 422(3):455-62. PubMed ID: 19548878
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels.
Mok MH; Fricker AC; Weil A; Kew JN
Neuropharmacology; 2009 Sep; 57(3):242-9. PubMed ID: 19523966
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological effects of some kynurenic acid analogs.
Nagy K; Plangár I; Tuka B; Gellért L; Varga D; Demeter I; Farkas T; Kis Z; Marosi M; Zádori D; Klivényi P; Fülöp F; Szatmári I; Vécsei L; Toldi J
Bioorg Med Chem; 2011 Dec; 19(24):7590-6. PubMed ID: 22079867
[TBL] [Abstract][Full Text] [Related]
15. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
16. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
[TBL] [Abstract][Full Text] [Related]
17. On the toxicity of kynurenic acid in vivo and in vitro.
Turski WA; Małaczewska J; Marciniak S; Bednarski J; Turski MP; Jabłoński M; Siwicki AK
Pharmacol Rep; 2014 Dec; 66(6):1127-33. PubMed ID: 25443745
[TBL] [Abstract][Full Text] [Related]
18. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
[TBL] [Abstract][Full Text] [Related]
19. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy.
Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J
J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457
[TBL] [Abstract][Full Text] [Related]
20. Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells.
Walczak K; Deneka-Hannemann S; Jarosz B; Zgrajka W; Stoma F; Trojanowski T; Turski WA; Rzeski W
Pharmacol Rep; 2014 Feb; 66(1):130-6. PubMed ID: 24905318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
